Skip to content
10-Q

Quarterly Report

Bohai Pharmaceuticals Group, Inc.

0001144204-13-029664

← back to feed
Filed
May 15, 2013 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2013 · May 15, 2013 17.86M sh
Stockholders Equity Q3 2013 · Mar 31, 2013 $102.18M
Stockholders Equity Q3 2013 · Jun 30, 2012 $86.5M
Current Liabilities Q3 2013 · Mar 31, 2013 $34.31M
Current Liabilities Q3 2013 · Jun 30, 2012 $30.43M
Total Liabilities Q3 2013 · Mar 31, 2013 $55.01M
Total Liabilities Q3 2013 · Jun 30, 2012 $58.9M
Current Assets Q3 2013 · Mar 31, 2013 $56.76M
Current Assets Q3 2013 · Jun 30, 2012 $62.18M
Total Assets Q3 2013 · Mar 31, 2013 $157.19M
Total Assets Q3 2013 · Jun 30, 2012 $145.4M
Shares Diluted Q3 2013 · Mar 31, 2012 23.09M sh
Shares Diluted Q3 2013 · Mar 31, 2012 23.09M sh
Capex Q3 2013 · Mar 31, 2012 $509.12K
Operating Cash Flow restated Q3 2013 · Mar 31, 2012 $15.7M
Cash And Equivalents Q3 2013 · Mar 31, 2012 $23.04M
Cash And Equivalents Q3 2013 · Jun 30, 2011 $13.34M
Eps Diluted Q3 2013 · Mar 31, 2012 $0.28
Eps Diluted Q3 2013 · Mar 31, 2012 $0.37
Eps Basic Q3 2013 · Mar 31, 2012 $0.30
Eps Basic Q3 2013 · Mar 31, 2012 $0.37
Sga Expense restated Q3 2013 · Mar 31, 2012 $19.15M
Sga Expense restated Q3 2013 · Mar 31, 2012 $52.87M
Rd Expense Q3 2013 · Mar 31, 2012 $0
Net Income Q3 2013 · Mar 31, 2012 $5.3M
Net Income Q3 2013 · Mar 31, 2012 $6.66M
Operating Income Q3 2013 · Mar 31, 2012 $8.27M
Operating Income Q3 2013 · Mar 31, 2012 $23.15M
Gross Profit Q3 2013 · Mar 31, 2012 $28.06M
Gross Profit Q3 2013 · Mar 31, 2012 $77.9M